Literature DB >> 10534589

Why is depression comorbid with chronic myofascial face pain? A family study test of alternative hypotheses.

B P Dohrenwend1, K G Raphael, J J Marbach, R M Gallagher.   

Abstract

A number of explanations have been proposed to account for findings that rates of depression are elevated in persons with chronic, non-malignant pain disorders (CNPDs); for example, that CNPDs are variants of depression (e.g. 'masked depression'), that the stress of living with CNPDs contribute to the onset of depression ('diathesis-stress'), or that the correlation of CNPDs and depression is a methodological artifact of studying treatment-seeking samples. These alternative hypotheses are tested for one specific CNPD, chronic myofascial face pain, using a family study methodology. The procedure was to conduct direct psychiatric interviews with 106 patients with a history of carefully diagnosed myofascial face pain, 118 acquaintance controls without personal histories of myofascial face pain, and a random sample of adult first degree relatives of these case and control probands. The probands were further subdivided into four roughly equal samples consisting of cases with and without personal histories of major depressive disorder (MDD), and controls with and without personal histories of MDD. Dates of initial onsets of myofascial face pain and MDD in patient probands were obtained from interviews and records. The main results were that, compared to control probands without personal histories of MDD, MDD and depressive spectrum disorders (DSD) were elevated in the first degree relatives of control probands with personal histories of early onset MDD, but not in the first degree relatives of myofascial face pain probands with or without personal histories of early or late onset MDD. This outcome is consistent with the hypothesis that living with chronic myofascial face pain contributes to elevated rates of depression. It is inconsistent with the alternative hypotheses that this CNPD is a variant of depression or that the elevated MDD rates are simply an artifact of selection into treatment. The implications of these results and additional results consistent with them are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10534589     DOI: 10.1016/s0304-3959(99)00100-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  20 in total

Review 1.  The role of psychosocial factors in temporomandibular disorders.

Authors:  G B Rollman; J M Gillespie
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Chronic facial pain: a multidisciplinary problem.

Authors:  G Madland; C Feinmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 3.  Nonpharmacologic approaches to the management of myofascial temporomandibular disorders.

Authors:  J J Sherman; D C Turk
Journal:  Curr Pain Headache Rep       Date:  2001-10

Review 4.  Myofascial pain: diagnosis and management.

Authors:  Steven B Graff-Radford
Journal:  Curr Pain Headache Rep       Date:  2004-12

5.  Non-invasive brain stimulation approaches to fibromyalgia pain.

Authors:  Baron Short; Jeffrey J Borckardt; Mark George; Will Beam; Scott T Reeves
Journal:  J Pain Manag       Date:  2009-01-01

6.  Exacerbated mechanical allodynia in rats with depression-like behavior.

Authors:  Qing Zeng; Shuxing Wang; Grewo Lim; Liling Yang; Ji Mao; Backil Sung; Yang Chang; Jeong-Ae Lim; Gongshe Guo; Jianren Mao
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

Review 7.  Comorbidity of fibromyalgia and psychiatric disorders.

Authors:  Dan Buskila; Hagit Cohen
Journal:  Curr Pain Headache Rep       Date:  2007-10

Review 8.  Cervical myofascial pain and headache.

Authors:  Joanne Borg-Stein
Journal:  Curr Pain Headache Rep       Date:  2002-08

9.  Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.

Authors:  A Kamanli; A Kaya; O Ardicoglu; S Ozgocmen; F Ozkurt Zengin; Y Bayik
Journal:  Rheumatol Int       Date:  2004-09-15       Impact factor: 2.631

Review 10.  [Chronic temporomandibular disorders].

Authors:  J C Türp; H J Schindler
Journal:  Schmerz       Date:  2004-04       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.